1 recruiting, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
Follow Azithromycin 250 MG: new trials by email Literature Review of Azithromycin 250 MG trials Research Report on Azithromycin 250 MG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hydroxychloroquine, Azithromycin in the Treatment of Covid-19 Hydroxychloroquine 200 Mg Oral Tablet, Azithromycin 250 MG - SARS-CoV-2 Pneumonia, COVID-19 | Phase 3 | Unknown | Centre Hôpital Universitaire Farhat Hached | 200 | 2020-07-01 | 2020-06-19 |
| CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections Clarithromycin 1000 MG, Azithromycin 250 mg, Rifampicin - Lung Infection, MAC Lung Disease | Phase 3 | Recruiting | Centre Hospitalier Universitaire, Amiens | 424 | 2018-02-05 | 2025-11-19 |
COVID-19 (1)
Centre Hospitalier Universitaire, Amiens (1) · Centre Hôpital Universitaire Farhat Hached (1)
France (1) · Tunisia (1)